Literature DB >> 397448

Physiologic vs pathologic myopia: genetics vs environment.

B J Curtin.   

Abstract

Physiologic myopia occurs as the result of a correlation failure of refraction components in the normal eye. Pathologic myopia is caused by excessive axial elongation that primarily involves the ora-equatorial area and the posterior pole. Peripheral fundus changes and posterior staphyloma formation are ophthalmoscopic evidences of this process. Heredity is the basic determinant of ocular refraction, but numerous agents produce both temporary and permanent myopias.

Entities:  

Mesh:

Year:  1979        PMID: 397448     DOI: 10.1016/s0161-6420(79)35466-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  21 in total

1.  Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients.

Authors:  J M Ruiz-Moreno; C de la Vega
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  Myopia in Singapore: taking a public health approach.

Authors:  B Seet; T Y Wong; D T Tan; S M Saw; V Balakrishnan; L K Lee; A S Lim
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

3.  Two- and three-dimensional topographic analysis of pathologically myopic eyes with dome-shaped macula and inferior staphyloma by spectral domain optical coherence tomography.

Authors:  Antonio García-Ben; Radua Kamal-Salah; Ignacio García-Basterra; Ana Gonzalez Gómez; María José Morillo Sanchez; Jose Manuel García-Campos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-17       Impact factor: 3.117

4.  Factors associated with macular complications in highly myopic eyes with dome-shaped macular configuration.

Authors:  Mumin Hocaoglu; M Giray Ersoz; Isil Sayman Muslubas; Serra Arf; Murat Karacorlu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-04       Impact factor: 3.117

5.  Ultrastructural analyses of internal limiting membrane excised from highly myopic eyes with myopic traction maculopathy.

Authors:  Reiji Yokota; Akito Hirakata; Nobutsugu Hayashi; Kazunari Hirota; Tosho Rii; Yuji Itoh; Tadashi Orihara; Makoto Inoue
Journal:  Jpn J Ophthalmol       Date:  2017-10-25       Impact factor: 2.447

6.  Intrachoroidal cavitation in myopic eyes.

Authors:  Ramesh Venkatesh; Kushagra Jain; Aditya Aseem; Sabitabh Kumar; Naresh Kumar Yadav
Journal:  Int Ophthalmol       Date:  2019-07-12       Impact factor: 2.031

7.  Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia.

Authors:  K Ohno-Matsui; T Yoshida; S Futagami; K Yasuzumi; N Shimada; A Kojima; T Tokoro; M Mochizuki
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

Review 8.  Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.

Authors:  Kelvin Yi Chong Teo; Wei Yan Ng; Shu Yen Lee; Chui Ming Gemmy Cheung
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

9.  Risk factors of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese patients.

Authors:  Yong-Hao Gu; Gen-Jie Ke; Lin Wang; Qi-Hong Gu; En-Liang Zhou; Hong-Biao Pan; Shi-Ying Wang
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

10.  Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.

Authors:  D S C Lam; W-M Chan; D T L Liu; D S P Fan; W W Lai; K K L Chong
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.